Abstract
Interpreting deep learning models typically relies on post-hoc saliency map techniques. However, these techniques often fail to serve as actionable feedback to clinicians, and they do not directly explain the decision mechanism. Here, we propose an inherently interpretable model that combines the feature extraction capabilities of deep neural networks with advantages of sparse linear models in interpretability. Our approach relies on straight-forward but effective changes to a deep bag-of-local-features model (BagNet). These modifications lead to fine-grained and sparse class evidence maps which, by design, correctly reflect the model’s decision mechanism. Our model is particularly suited for tasks which rely on characterising regions of interests that are very small and distributed over the image. In this paper, we focus on the detection of Diabetic Retinopathy, which is characterised by the progressive presence of small retinal lesions on fundus images. We observed good classification accuracy despite our added sparseness constraint. In addition, our model precisely highlighted retinal lesions relevant for the disease grading task and excluded irrelevant regions from the decision mechanism. The results suggest our sparse BagNet model can be a useful tool for clinicians as it allows efficient inspection of the model predictions and facilitates clinicians’ and patients’ trust.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the German Science Foundation (BE5601/8-1 and the Excellence Cluster 2064 'Machine Learning -New Perspectives for Science', project number 390727645), the Carl Zeiss Foundation in the project 'Certification and Foundations of Safe Machine Learning Systems in Healthcare' and the Hertie Foundation. The authors thank the International Max Planck Research School for Intelligent Systems (IMPRS-IS) for supporting Kerol Djoumessi and Indu Ilanchezian. We also thank Sarah Muller for help with image preprocessing, and Murat Seckin Ayhan for providing an automated quality grading tool
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://www.kaggle.com/c/diabetic-retinopathy-detection/data
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
KEROL.DJOUMESSI{at}UNI-TUEBINGEN.DE
INDU.ILANCHEZIAN{at}UNI-TUEBINGEN.DE
LAURA.KUEHLEWEIN{at}MED.UNI-TUEBINGEN.DE
HANNA.FABER{at}MED.UNI-TUEBINGEN.DE
CHRISTIAN.BAUMGARTNER{at}UNI-TUEBINGEN.DE
BUBACARR{at}AIMS.AC.ZA
PHILIPP.BERENS{at}UNI-TUEBINGEN.DE
LISA.KOCH{at}UNI-TUEBINGEN.DE
Data Availability
All data produced are available online at https://www.kaggle.com/c/diabetic-retinopathy-detection/data All annotation data produced in the present study are available upon reasonable request to the authors
